Based on the above reports and the findings of this study, we speculate that OFI-F may act as a potent agonist of sirtuins, ameliorating renal inflammation and fibrosis during the progression of DN by regulating the Sirtuins/NF-κB related pathway. The gene discussed is NFKB1; the disease is liver dysplastic nodule.